Sr. Director, US Team Lead, LORBRENA/BRAF Lung

Role

Senior commercial leader overseeing the US Precision Medicine Thoracic Franchise for Pfizer's oncology portfolio, focusing on biomarker-driven therapies for NSCLC, including LORBRENA and BRAFTOVI + MEKTOVI.

Responsibilities

• develop and execute AI-enabled marketing strategies leveraging machine learning, predictive analytics, and next-best-action tools;
• lead cross-functional teams to align brand, diagnostic, and customer engagement strategies;
• set multi-year portfolio visions, anticipate market shifts, and shape lifecycle management;
• connect marketing efforts to patient outcomes through metrics and feedback loops;
• coordinate with Market Access to address reimbursement challenges;
• lead and develop a high-performing marketing team;
• influence senior leadership with strategic insights;
• ensure compliance and effective communication across channels.

Qualifications

• 12+ years pharma experience with proven success in AI/data-driven marketing, US product launches, and lifecycle management;
• strong leadership, strategic thinking, cross-functional collaboration, and communication skills;
• experience in oncology or biomarker-driven therapies preferred.

High-Value

oncology (NSCLC), biomarker-driven, precision medicine, AI-enabled marketing, lifecycle planning, cross-functional leadership, US market.

Work Setup

multiple US locations, some travel (~20%), fast-paced, data-rich environment.